Specialty: Primary Care, Primary sub-specialty: Health services and delivery research
Conditions
Interventions
In each of the four locations, one Pharmacist Independent Prescriber (PIP) and one GP, with whom the PIP will work for the three month duration of the study, will be recruited. The participating GP pr
Sponsors
NHS South Norfolk CCG
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Independent Prescribing Pharmacist (PIP) inclusion criteria: 1. Registered with The General Pharmaceutical Council as a pharmacist independent prescriber 2. Following training can demonstrate competence to deliver the CHIPPS service Specification 3. Ability to work flexibly and commit a minimum of 16 hours a month to deliver the service for three months GP inclusion criteria: GP must manage a minimum of 15 patients across 1-2 care homes Care Home inclusion criteria: 1. Care Quality Commission (CQC) registered specialism as caring for adults over 65 2. Primarily caring for residents over 65 years# Resident Inclusion criteria 1. Residents currently prescribed at least one regular medication 2. Residents or their appropriate representative who are/is able to provide informed consent/assent 3. Permanent resident in care home (not registered for respite care/temporary resident) 4. Residents should be 65 years or over 5. Under the care of the participating GP practice
Exclusion criteria
Exclusion criteria: Independent Prescribing Pharmacist (PIP) exclusion criteria: Substantive employment with the community pharmacy (branch/store) which supplies medicines to the care home with which the PIP would work. GP exclusion criteria: GPs managing patients across several (>2) care homes if they manage less than 15 patients in total across their two largest homes. Care Home exclusion criteria: 1. Care homes which receive regular (i.e. a visit frequency = monthly) additional medication focussed services 2. Care homes which do not have carers on site 24 hours a day 3. Care homes which are currently under formal investigation with the Care Quality Commission (CQC) Resident exclusion criteria: 1. Residents who are currently receiving end of life care (equivalent to yellow (stage C) of the Gold Standards Framework prognostic indicator) 2. Resident with additional limitations on their residence (e.g. held securely) 3. Participating in another research study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Adverse drug events are measured by reviewing the patient notes at baseline and at 3 months 2. Health-service utilisation and associated costs are measured by reviewing the patient notes at baseline and three months 3. Medication appropriateness is measured using STOPP/START and Drug Burden Index at baseline and three months 4. Quality of life is measured using EQ=5D and QUALIDEM at baseline and three months 5. Mortality is measured by notification from the care home manager or PIP at any point during the three months of the study 6. Falls are measured by reviewing the patient notes at baseline and three months 7. Physical functioning is measured using the Barthel Index at baseline and three months 8. Cognitive functioning is measured using the Mini–Mental State Examination (MMSE) at baseline and three months 9. Care home staff job satisfaction is measured using qualitative interviews at three months | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
England, Northern Ireland, Scotland, United Kingdom
Contacts
Public ContactAnnie Blyth
Outcome results
None listed